Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tanya Simuni

Showing results (101-110 of 196) with videos related to

Pageof 20
Sort By:
Movement Disorders : Official Journal of the Movement Disorder Society|May 16, 2013
Diffusion tensor imaging of Parkinson's disease, atypical parkinsonism, and essential tremorJaney Prodoehl, Hong Li, Peggy J Planetta, et al.
Journal of Parkinson'S Disease|October 8, 2015
Peripheral Biomarkers of Parkinson's Disease Progression and Pioglitazone EffectsDavid K Simon, Tanya Simuni, Jordan Elm, et al.
Journal of Parkinson'S Disease|August 28, 2019
Predicting Progression in Parkinson's Disease Using Baseline and 1-Year Change MeasuresLana M Chahine, Andrew Siderowf, Janel Barnes, et al.
Digital Biomarkers|March 17, 2020
Metadata Concepts for Advancing the Use of Digital Health Technologies in Clinical ResearchReham Badawy, Farhan Hameed, Lauren Bataille, et al.
Movement Disorders Clinical Practice|May 31, 2024
Anticipating Tomorrow: Tailoring Parkinson's Symptomatic Therapy Using Predictors of OutcomeRonald B Postuma, Daniel Weintraub, Tanya Simuni, et al.
Parkinsonism & Related Disorders|September 28, 2020
Cognitive impairment in Parkinson's disease: Associations between subjective and objective cognitive decline in a large longitudinal studyKelly A Mills, Ruth B Schneider, Marie Saint-Hilaire, et al.
Stereotactic and Functional Neurosurgery|October 26, 2006
Long-term outcomes of bilateral subthalamic nucleus stimulation in patients with advanced Parkinson's diseaseGrace S Liang, Kelvin L Chou, Gordon H Baltuch, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|May 31, 2017
Longitudinal assessment of excessive daytime sleepiness in early Parkinson's diseaseAmy W Amara, Lama M Chahine, Chelsea Caspell-Garcia, et al.
The Lancet. Neurology|July 21, 2023
Safety and efficacy of venglustat in GBA1-associated Parkinson's disease: an international, multicentre, double-blind, randomised, placebo-controlled, phase 2 trialNir Giladi, Roy N Alcalay, Gary Cutter, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|September 30, 2010
A recommended scale for cognitive screening in clinical trials of Parkinson's diseaseKelvin L Chou, Melissa M Amick, Jason Brandt, et al.
Pageof 20

Showing results (101-110 of 196) with videos related to

Sort By:
Pageof 20
Movement Disorders : Official Journal of the Movement Disorder Society|May 16, 2013
Diffusion tensor imaging of Parkinson's disease, atypical parkinsonism, and essential tremorJaney Prodoehl, Hong Li, Peggy J Planetta, et al.
Journal of Parkinson'S Disease|October 8, 2015
Peripheral Biomarkers of Parkinson's Disease Progression and Pioglitazone EffectsDavid K Simon, Tanya Simuni, Jordan Elm, et al.
Journal of Parkinson'S Disease|August 28, 2019
Predicting Progression in Parkinson's Disease Using Baseline and 1-Year Change MeasuresLana M Chahine, Andrew Siderowf, Janel Barnes, et al.
Digital Biomarkers|March 17, 2020
Metadata Concepts for Advancing the Use of Digital Health Technologies in Clinical ResearchReham Badawy, Farhan Hameed, Lauren Bataille, et al.
Movement Disorders Clinical Practice|May 31, 2024
Anticipating Tomorrow: Tailoring Parkinson's Symptomatic Therapy Using Predictors of OutcomeRonald B Postuma, Daniel Weintraub, Tanya Simuni, et al.
Parkinsonism & Related Disorders|September 28, 2020
Cognitive impairment in Parkinson's disease: Associations between subjective and objective cognitive decline in a large longitudinal studyKelly A Mills, Ruth B Schneider, Marie Saint-Hilaire, et al.
Stereotactic and Functional Neurosurgery|October 26, 2006
Long-term outcomes of bilateral subthalamic nucleus stimulation in patients with advanced Parkinson's diseaseGrace S Liang, Kelvin L Chou, Gordon H Baltuch, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|May 31, 2017
Longitudinal assessment of excessive daytime sleepiness in early Parkinson's diseaseAmy W Amara, Lama M Chahine, Chelsea Caspell-Garcia, et al.
The Lancet. Neurology|July 21, 2023
Safety and efficacy of venglustat in GBA1-associated Parkinson's disease: an international, multicentre, double-blind, randomised, placebo-controlled, phase 2 trialNir Giladi, Roy N Alcalay, Gary Cutter, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|September 30, 2010
A recommended scale for cognitive screening in clinical trials of Parkinson's diseaseKelvin L Chou, Melissa M Amick, Jason Brandt, et al.
Pageof 20